
This interactive tool allows you to explore the global burden of AD in pediatric patients <12 years from the PEDISTAD Study.

Join Dr. Leonard Bacharier as he discusses the definition of clinical remission in pediatric asthma and how it can represent a potential target in pediatric asthma management.

Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients

Navigate through this interactive infographic to learn more about why lung function is important to monitor in pediatric patients with asthma and the noninvasive procedures that are available for implementation in clinical practice.

An interactive tool used to explore the global burden of atopic dermatitis in children and adolescents.

In this exclusive video interview, Dr Amy Paller discusses two topics: 1) The importance of CCL17 (TARC) as a biomarker in pediatric patients with AD, and 2) How IL-4 and IL-13 contribute to skin barrier dysfunction in AD.

In this video from the April 2025 WCPD symposium, Dr Paula Luna discusses the multidimensional disease burden in pediatric patients with AD and the data regarding how early intervention may lead to long-term disease control and a reduced risk of developing non-atopic comorbidities.
Join experts Jonathan Spergel, MD, PhD, Wanda Phipatanakul, MD, MS, and Jerry Ellen Schonfeld, CPNP, at an educational symposium as they investigate the role of type 2 inflammation in pediatric diseases. The speakers will also discuss the difficulties in diagnosis and burdens patients and their families face.

Professor of Pediatrics and Dermatology in the Department of Pediatrics, Division of Dermatology at Saint Louis University School of Medicine, US

Associate Professor, Department of Pediatrics, McGill University | Montreal, Quebec, Canada

Pediatric Dermatologist, DERM360 | Medical Director, Pediatric Skin Research | Miami, Florida, USA

Consultant Pediatric Allergist at the Department of Pediatrics of the University of Padova, Italy